Respiratory syncytial virus infection in infants in rural Nepal  by Chu, Helen Y. et al.
Journal of Infection (2016) 73, 145e154www.elsevierhealth.com/journals/jinfRespiratory syncytial virus infection in
infants in rural NepalHelen Y. Chu a,*, Joanne Katz b, James Tielsch c,
Subarna K. Khatry d, Laxman Shrestha e, Steven C. LeClerq d,
Amalia Magaret f, Jane Kuypers f, Mark Steinhoff g,
Janet A. Englund haDepartment of Medicine, University of Washington, Seattle, WA, USA
bDepartment of International Health, Johns Hopkins University, Baltimore, MD, USA
cDepartment of Global Health, George Washington University, Washington, D.C., USA
dNepal Nutrition Intervention Project-Sarlahi, Sarlahi District, Nepal
eDepartment of Pediatrics and Child Health, Institute of Medicine, Tribhuvan University, Kathmandu,
Nepal
fDepartment of Laboratory Medicine, University of Washington, Seattle, WA, USA
gDepartment of Global Health, Cincinnati Children’s Hospital, Cincinnati, OH, USA
hDepartment of Pediatrics, University of Washington, Seattle Children’s Research Institute, Seattle,
WA, USAAccepted 19 May 2016
Available online 27 May 2016KEYWORDS
Respiratory syncytial
virus;
Pneumonia;
Preterm birth;
Resource-limited setting* Corresponding author. University of
WA 98104, USA. Tel.: þ1 (206) 897 66
E-mail address: helenchu@uw.edu
http://dx.doi.org/10.1016/j.jinf.2016
0163-4453/ª 2016 The Authors. Publis
the CC BY license (http://creativecomSummary Objectives: Respiratory syncytial virus (RSV) pneumonia is a leading cause of in-
fant mortality worldwide. The risk of RSV infection associated with preterm birth is not
well-characterized in resource-limited settings. We aimed to obtain precise estimates of risk
factors and disease burden of RSV in infants in rural southern Nepal.
Methods: Pregnant women were enrolled, and along with their infants, followed to six months
after birth with active weekly home-based surveillance for acute respiratory illness (ARI). Mid-
nasal swabs were obtained and tested for RSV by PCR for all illness episodes. Birth outcomes
were assessed at a postpartum home visit.
Results: 311 (9%) of 3509 infants had an RSV ARI. RSV ARI incidence decreased from 551/1000
person-years in infants born between 28 and 31 weeks to 195/1000 person-years in infants born
full-term (p Z 0.017). Of 220 infants (71%) evaluated in the health system, 41 (19%) visited a
hospital or physician. Of 287 infants with an assessment performed, 203 (71%) had a lower res-
piratory tract infection.Washington Division of Allergy & Infectious Diseases, Harborview Medical Center, MS 359779, Seattle,
50; fax: þ1 (206) 685 0552.
(H.Y. Chu).
.05.007
hed by Elsevier Ltd on behalf of The British Infection Association. This is an open access article under
mons.org/licenses/by/4.0/).
146 H.Y. Chu et al.Conclusions: In a rural south Asian setting with intensive home-based surveillance, RSV caused
a significant burden of respiratory illness. Preterm infants had the highest incidence of RSV
ARI, and should be considered a priority group for RSV preventive interventions in resource-
limited settings.
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Pneumonia is the primary infectious cause of death in
children under age five worldwide. Respiratory syncytial
virus (RSV) is the most common cause of viral pneumonia,
and greater than 99% of deaths due to RSV are estimated to
occur in resource-limited settings.1,2 No vaccine is
currently available for RSV, though several are under devel-
opment for both infants and pregnant women. Precise esti-
mates of baseline disease burden are needed to guide
vaccine trials and set priorities for national immunization
programs. Preterm birth, low birthweight, indoor air pollu-
tion, malnutrition, household crowding, and bacterial and
parasitic infections have been shown to increase risk of se-
vere pneumonia, and may influence morbidity and mortal-
ity due to RSV in resource-limited settings.1
Studies describing RSV in resource-limited settings have
primarily used samples collected in clinics or hospitals. A
large proportion of deaths due to respiratory disease or
pneumonia may occur outside of these settings. This may
lead to an underestimate of true population-based disease
burden.3,4 Additionally, many studies have not captured the
impact of birth outcomes on RSV infection risk.5 Preterm
birth is the primary risk factor for severe RSV disease in
developed countries and is an indication for prophylaxis
with palivizumab, a monoclonal antibody against RSV.6 How-
ever, the majority of preterm birth is estimated to occur in
Africa and Asia. There is a lack of data from South Asia eval-
uating the association of preterm birth with RSV disease.
The objective of this study was to characterize the
impact of prematurity and low birthweight on RSV acute
respiratory illness (ARI) in very young infants from birth to
six months of age using active weekly home-based surveil-
lance for respiratory viral infections in Nepal.
Materials and methods
Two consecutive, population-based, randomized, placebo-
controlled trials of maternal influenza immunization were
conducted in annual cohorts in the sub-tropical plains of
rural southern Nepal from April 2011 to May 2014.7 Women
were enrolled in the second to third trimester of pregnancy
and followed, along with their infants, with weekly home-
based visits until 180 days after birth. Clinical and sociode-
mographic data were collected at enrollment and at weekly
visits. Birthweight was measured at a postpartum home
visit. Infant ARI was defined as having any of the following:
fever, cough, wheeze, difficult or rapid breathing, or a
draining ear. For ARI episodes, health care worker collected
mid-nasal swabs and performed an assessment of illness
severity. Households were visited on a weekly basis, andswabs were collected if the infant met criteria for a respi-
ratory illness in the past seven days. Swabs were trans-
ported in a temperature-stable nucleic acid buffer
(Primestore, Austin, TX, U.S.A.) to the field laboratory,
where they were aliquoted and stored at 80 C until trans-
port to the University of Washington Virology Laboratory in
Seattle, WA, U.S.A. Virologic testing was performed for RSV
using real-time polymerase chain reaction (qPCR).8
Data were analyzed using SAS 9.4 (Cary, NC). Incidence
of RSV ARI was calculated using days of follow-up from birth
until end of study or loss to follow-up. Days with symptoms
as well as seven subsequent days were excluded from days
at risk. An RSV epidemic period was defined as including
weeks in which at least one case was detected, and at least
three cases were found in any contiguous three-week
period.9 Incidence rates were reported for RSV ARIs per
1000 person-years of observation overall and during RSV
epidemic periods.
Birthweight was included if obtained <72 h after birth.
Low birthweight was defined as <2500 g. Preterm birth
was defined as <37 weeks completed gestation. Gesta-
tional age was calculated according to last menstrual
period based on a house-to-house census conducted every
five weeks of all women of childbearing age.10 If they had
a missed period, then a urine pregnancy test was per-
formed, and they were enrolled in the study if their urine
pregnancy test was positive. Last menstrual period,
therefore, was used to date the study with a five week
recall period. Small-for-gestational-age (SGA) was defined
according to the Alexander criteria.11 Z-scores were
calculated using the WHO child growth standards.12 A
household was defined as the persons sharing a common
cookstove. Household density was the numbers of per-
sons/room in the household. An RSV ARI was defined as
the presence of any symptoms occurring for a minimum
of one day with a mid-nasal swab obtained and RSV de-
tected on qPCR assay. Illness episodes were considered
unique if they were separated by seven symptom-free
days. Only the primary RSV ARI was included in this anal-
ysis. Lower respiratory tract infection (LRTI) was defined
according to the World Health Organization Integrated
Management of Childhood Illness criteria as cough and/
or difficulty breathing in association with age-specific ta-
chypnea or wheezing. In addition to the above definition,
LRTI also included severe or very severe pneumonia. Se-
vere pneumonia was defined as cough and/or difficulty
breathing with chest wall indrawing. Very severe pneu-
monia was defined as cough and/or difficulty breathing
with lethargy or unconsciousness, convulsions, cyanosis
or inability to feed/drink or vomiting everything. Upper
respiratory tract infection (URTI) was defined as a RSV
ARI that did not meet criteria for LRTI.13
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using Poisson regression, using log time at risk as the offset.
Because of the highly seasonal nature of RSV in our study,
we performed a sensitivity analysis restricted to infants
under surveillance during the RSV epidemic period. A
multivariate Poisson regression model was performed to
evaluate risk factors for RSV ARI, using backward elimina-
tion to result in a final, parsimonious model. Characteristics
of infections occurring within two months versus two to six
months of birth were compared using Wilcoxon tests for
continuous measures and c2 tests for categorical ones. Mea-
sures potentially associated with LRTI versus upper respira-
tory tract infections (URTI) were evaluated similarly.
Poisson for correlated data, or a generalized estimating
equation, was used to evaluate whether RSV ARI risk
changed with age, by including each infant six times in
the model, once for each month of life.
IRB approval for the study was obtained from the Johns
Hopkins University Bloomberg School of Public Health,
Seattle Children’s Hospital, Cincinnati Children’s Hospital,
the Institute of Medicine at Tribhuvan University, and the
Nepal Health Research Council. The trial in which this sub-
study was conducted is registered at Clinicaltrials.gov
(NCT01034254).Results
Altogether, 3693 women enrolled during pregnancy and
gave birth to 3646 live-born infants. A total of 3509 infants
with weekly illness surveillance were followed for 1461
person-years. Over 75,000 weekly visits were conducted
with collection of 4204 nasal swabs for infant ARI (Fig. 1).
For all infants in the study, the median duration of surveil-
lance was 180 days (IQR 170e180), with 0.5% of the chil-
dren in the study having follow-up for less than 150 days.
Approximately 90% of ARIs overall identified in infants
had a swab taken, including 91% of those without fever
and 89% of those with fever. In this cohort, 311 (9%) infants
had a primary RSV ARI (Table 1).
RSV was highly seasonal, with a peak between
September and November over three years (Fig. 2A). Over-
all incidence was 213/1000 person-years, while the inci-
dence during RSV epidemic periods was 443/1000 person-
years (by year, 2011e2012: 439/1000; 2012e2013: 407/
1000; 2013e2014: 518/1000). The incidence of RSV ARI by
age was lowest in the first month of life (107/1000
person-years) and higher in each of months two through
five (246, 222, 256, and 220/1000 person-years, p < 0.001
for each), but not higher in month six (160/1000 person-
years, pZ 0.12; Fig. 2B). By gestational age, the incidence
of RSV decreased from 551/1000 person-years in infants
born between 28 and 31 weeks to 195/1000 person-years
in infants born at 37 weeks or later (Fig. 2C, p Z 0.017).
Thirty (10%) infants with RSV were born at a gestational
age of 34 weeks or less.
On bivariate analysis, the single maternal factor asso-
ciated with risk of RSV ARI was maternal education
(Incidence rate ratio (RR): 0.95; 95% CI: 0.91e0.99;
Table 1). Household factors included use of an open indoor
biomass cookstove (IRR: 2.00; 95% CI: 1.10e3.64), and
presence of a household latrine (IRR: 0.69; 95% CI:0.47e1.00). Other factors not significantly associated
were number of persons per room (IRR: 1.01; 95% CI:
0.96e1.06), number of other children (IRR: 1.09; 95% CI:
0.98e1.20), and number of other children under age five
(IRR: 1.22; 95% CI: 0.99e1.51). Infant factors included pre-
term birth (IRR: 1.78; 95% CI: 1.12e2.83), and birth during
monsoon season (typically late June to end of September;
IRR: 5.34; 95% CI: 3.36e8.47). The risk of RSV ARI was not
different between preterm infants who were or were not
SGA (p Z 0.39).
We conducted a sensitivity analysis restricted to the RSV
epidemic period in which 47% of follow-up (688/1461
person-years) and 98% of infections (305/311) occurred.
Bivariate results are strikingly similar, though the increase
in RSV ARI associated with monsoon season correspondingly
decreased from an IRR of 5.34 to 2.60 (Table 1). On multi-
variate analysis of the full risk period initially including
maternal education, maternal literacy, use of open cook-
stove, children under age five, household latrine, gesta-
tional age and monsoon season, the only risk factors that
remained significant for RSV ARI were maternal years of ed-
ucation (IRR: 0.95; 95% CI: 0.91e0.99) and monsoon season
of birth (IRR: 5.34; 95% CI: 3.32e8.58).
The median age at RSV ARI was 12 weeks (IQR, 7e17
weeks). As compared to older infants, infants with a
primary RSV ARI under age two months had similar duration
of fever, wheezing or difficulty breathing (Table 2). A slight
difference was seen between infants < two months versus
two to six months in days of cough (three vs. four, respec-
tively; p Z 0.035). Most infants with RSV ARI had a health
care visit for their illness (n Z 220; 71%). Of these, 41
(13%) infants were seen at a hospital (nZ 4) or by a physi-
cian (nZ 37), while the rest were seen at a local health fa-
cility, by a local healer or at a medicine shop. Overall infant
hospitalization rate was 2.7/1000 person-years. One (1%)
infant died following RSV ARI, while 46 (1%) of infants
without RSV ARI died of other etiologies, including pneu-
monia, diarrhea, preterm birth and congenital abnormal-
ities. The one death was a 7 week old male infant born at
31 weeks gestation. He had five days of fever, cough, and
difficulty breathing, and was seen for care at a health
care facility and prescribed antibiotics. His caregiver re-
ported that after being put to bed, he was found to have
stopped breathing one hour later.
Of 311 infants with RSV ARI, 287 (92%) had family-
reported symptoms by which to assess LRTI, and 246 (79%)
had a clinical assessment performed by study workers
trained to collect signs and symptoms of respiratory illness.
A total of 203 of 287 (71%) of infants had LRTI by any
criterion. Of the 246 infants with a clinical assessment, six
(2%) had severe pneumonia and 24 (10%) had very severe
pneumonia. Those with very severe pneumonia had the
following qualifying criteria: inability to feed/drink
(n Z 21; 88%), chest indrawing (n Z 7; 29%), or lethargy/
unconsciousness (n Z 5; 21%). Infants with LRTI were no
more likely to seek a higher level of care for their illness
than those with an URTI (p value for trend Z 0.85; Fig. 3).
When comparing infants with and without LRTI, no signifi-
cant differences were seen in maternal education, number
of children in the household, or use of an open indoor cook-
stove (Table 3). A trend was seen towards increased
numbers of preterm infants with LRTI.
1 
1Pneumonia: cough and/or difficulty breathing in association with age-specific tachypnea or wheezing.  
2Severe pneumonia: cough and/or difficulty breathing in association with chest wall indrawing.  
3Very severe pneumonia: cough and/or difficulty breathing in association with lethargy or unconsciousness, 
convulsions, cyanosis or inability to feed/drink vomits everything. 
311 (9%) infants with a primary RSV 
illness episode 
• 220 (71%) with a health care    
visit for RSV illness 
• 41 (13%) seen at a hospital         
or by a physician 
• 24 (8%) missing symptom 
reporting for pneumonia 
3198 infants without           
RSV illness
3509 infants enrolled and 
followed for 1483 person-years 
3693 pregnant women enrolled 
and gave birth to 3646 live-born 
infants 
24/246 (10%) with 
very severe 
pneumonia3 
1 (0.3%) infant 
death due to RSV 
203/287 (71%) with RSV-
associated LRTI 
• 41 (14%) missing clinical 
assessment for severity 
determination 
6/246 (2%) with 
severe pneumonia2 
but not very severe 
132/246 (54%) with 
pneumonia1 that is 
neither severe nor 
very severe 
Figure 1 Flow diagram showing infants followed in the study from birth until 180 days of age.
148 H.Y. Chu et al.Of the 2622 infants with growth measured at six months,
no significant difference in six month weight or length was
observed between surviving infants with and without RSV
ARI or when comparing infants with RSV-associated URTI vs.
LRTI (Tables 1 and 3). The Z-scores of infants with RSV aver-
aged 1.1 for weight-for-age, as compared to 1.0 for
weight-for-age in those without RSV ARI (p Z 0.63).Conclusions
In this large prospective population-based study using
active home-based weekly surveillance of infants in rural
Nepal, 9% of infants experienced a symptomatic RSV acute
respiratory illness in the first six months of life. Most infants
Table 1 Risk factors for infant RSV acute respiratory illness overall and during RSV season.
Risk factors for RSV Characteristic n (%) or median (IQR) Overall follow-up RSV season only
Uninfected (n Z 3198) RSV-infected (n Z 311) IRR (95% CI) p-Value IRR (95% CI) p-Value
Maternal primiparity 1355 (42.5%) 109 (35%) 0.75 (0.51, 1.10) 0.14 0.78 (0.54, 1.12) 0.18
Maternal age (n Z 3301) 23 (20e26) 22 (20e26) 1.00 (0.96, 1.04) 0.99 0.99 (0.96, 1.04) 0.79
Maternal education (yrs) (n Z 3237) 5 (0e10) 0 (0e8) 0.95 (0.91, 0.99) 0.020 0.95 (0.91, 0.99) 0.018
Maternal smoking (n Z 3238) 93/2960 (3.1%) 12/278 (4.3%) 1.36 (0.53, 3.49) 0.52 1.41 (0.57, 3.50) 0.46
Maternal literacy (n Z 3239) 1819/2961 (61.4%) 148/278 (53.2%) 0.72 (0.49, 1.06) 0.092 0.71 (0.49, 1.04) 0.078
Number of children under age
15 in household
2 (1e3) 2 (1e3) 1.09 (0.98, 1.20) 0.10 1.07 (0.97, 1.18) 0.15
Number of children under age
five in household
0 (0e1) 1 (0e1) 1.22 (0.99, 1.51) 0.064 1.19 (0.96, 1.46) 0.11
Madeshi ethnicity 1302 (42.3%) 135 (45.5%) 1.18 (0.81, 1.71) 0.39 1.16 (0.80, 1.66) 0.43
Number of persons in household 7 (5e10) 7 (5e10) 1.01 (0.96, 1.06) 0.62 1.01 (0.96, 1.05) 0.77
Open indoor cookstove 2474 (80.3%) 266 (89.3%) 2.00 (1.10, 3.64) 0.023 1.88 (1.03, 3.45) 0.041
Number of persons/room 2.75 (2e4) 3 (2e5) 1.05 (0.98, 1.12) 0.15 1.04 (0.97, 1.10) 0.26
Household latrine 1554 (50.5%) 121 (40.7%) 0.69 (0.47, 1.00) 0.053 0.70 (0.48, 1.02) 0.061
Brahmin caste 341 (11.1%) 26 (8.8%) 0.78 (0.40, 1.51) 0.46 0.73 (0.39, 1.40) 0.35
Male sex of infant 1676 (52.4%) 175 (56.3%) 1.16 (0.80, 1.68) 0.44 1.13 (0.80, 1.61) 0.49
Gestational age, weeks 39.7 (38.4e40.9) 39.4 (37.9e40.7) 0.92 (0.85, 0.98) 0.017 0.92 (0.86, 0.99) 0.027
Preterm birth 375 (11.7%) 60 (19.3%) 1.78 (1.12, 2.83) 0.014 1.70 (1.09, 2.66) 0.019
Birthweight, kg (n Z 2738) 2.8 (2.5e3.08) 2.76 (2.45e3.07) 0.78 (0.51, 1.21) 0.27 0.88 (0.58, 1.33) 0.54
Low birthweight (n Z 2738) 606/2479 (24.4%) 72/259 (27.8%) 1.21 (0.78, 1.89) 0.39 1.14 (0.75, 1.73) 0.54
Monsoon season birth (birth
between JuneeSept)
1299 (40.6%) 248 (79.7%) 5.34 (3.36, 8.47) <0.0001 2.60 (1.66, 4.08) <0.0001
Small for gestational age (n Z 2737) 1354/2478 (54.6%) 140/259 (54.1%) 0.99 (0.67, 1.48) 0.97 0.92 (0.63, 1.34) 0.67
Breastfeeding at birth 2624 (82.3%) 260 (83.6%) 0.97 (0.59, 1.58) 0.89 0.93 (0.58, 1.48) 0.76
Six month weight, kg (n Z 2622) 6.8 (6.2e7.4) 6.7 (6.2e7.4) 0.96 (0.79, 1.18) 0.73 0.97 (0.80, 1.18) 0.79
Six month length, cm (n Z 2621) 64.4 (62.7e66.1) 64.3 (62.1e65.8) 0.96 (0.90, 1.03) 0.29 0.96 (0.90, 1.02) 0.21
6 mo Z score for weight (n Z 2622) 1.0 (1.8 to 0.3) 1.1 (1.9 to 0.4) 0.95 (0.80, 1.12) 0.53 0.96 (0.82, 1.13) 0.63
6 mo Z score for length (n Z 2621) 1.0 (1.8 to 0.3) 1.2 (1.9 to 0.5) 0.90 (0.78, 1.05) 0.17 0.89 (0.77, 1.03) 0.13
Mortality 46 (1.4%) 1 (0.3%) 0.91 (0.04, 23.21) 0.96 0.79 (0.04, 16.79) 0.88
* Ns and denominators shown when at least 5% of data missing overall for that characteristic.
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Figure 2 A. Seasonality of RSV over three seasons, from 2011 to 2014, in rural southern Nepal using active-home based surveil-
lance. Overall incidence was 213/1000 person-years, while the incidence during RSV epidemic periods was 443/1000 person-years
(by year, 2011e2012: 439/1000; 2012e2013: 407/1000; 2013e2014: 518/1000). B. Incidence based graph of RSV by age in months.
The incidence of RSV ARI by age was lowest in the first month of life (107/1000 person-years) and higher in each of months two
through five (246, 222, 256, and 220/1000 person-years, p < 0.001 for each), but not higher in month six (160/1000 person-
years, p Z 0.12). C. Incidence based graph of RSV by gestational age (very preterm: 28e31, preterm: 32e34, late-preterm:
35e36, term: >37). By gestational age, the incidence of RSV decreased from 551/1000 person-years in infants born between 28
and 31 weeks to 195/1000 person-years in infants born at 37 weeks or later (Fig. 2C, p Z 0.017).
150 H.Y. Chu et al.with RSV had a lower respiratory tract infection or accessed
the health care system. The incidence of RSV ARI was
highest in preterm infants, and decreased significantly with
increasing gestational age. Our results quantify a significant
burden of disease that could be mitigated through direct
interventions, such as maternal vaccination.
In this study, mothers were surveyed for pregnancy
every five weeks, allowing for accurate dating of gesta-
tional age in a region of the world where prenatal care,
including first trimester ultrasound, is not routinelyavailable. In addition, the majority of birthweights were
measured <72 h after birth in a setting where w60% of
mothers deliver at home. These aspects of the study design
allow for an accurate assessment of risk for RSV ARI in
preterm, low birthweight infants in rural south Asia. We
find that the incidence of RSV ARI was highest in preterm
infants, and decreased with increasing gestational age.
Moreover, 10% of the cases of RSV ARI occurred in infants
born at 34 weeks gestation or younger. Similar findings been
described in hospital-based studies conducted in developed
Table 2 RSV illness episode characteristics in infants with RSV acute respiratory illness from birth to two months compared to
those age 2e6 months.
RSV illness episode characteristics
Median (min, max) or n (%)
Birth to 2 months (n Z 106) 2e6 months (n Z 205) p-Value
Days of symptoms
Fever 1 (0e11) 2 (0e16) 0.10
Cough 3 (0e17) 4 (0e19) 0.035
Wheeze 2 (0e25) 3 (0e11) 0.66
Difficulty breathing 2 (0e13) 2 (0e12) 0.60
Any symptoms 4 (0e26) 5 (0e21) 0.15
Visit for care (Y/N) 31 (29) 60 (29) 0.29a
No visit
Medicine shop or local doctor 17 (16) 51 (25)
Sub-health post or health post 41 (39) 70 (34)
Doctor, nursing home or hospital 17 (16) 24 (12)
WHO Integrated Management of
Childhood Illness criteria
n Z 82 n Z 164
Chest indrawing 8 (10) 6 (4) 0.052
Lethargy/unconsciousness 3 (4) 2 (1) 0.21
Convulsions 0 (0) 0 (0) e
Cyanosis 1 (1) 1 (1) 0.62
Inability to feed/drink or vomits everything 10 (12) 11 (7) 0.16
Lower respiratory tract infection (n Z 203) 70 (71) 133 (71) 0.99
Severe or very severe pneumonia (n Z 30) 14 (17) 16 (10) 0.098
Very severe pneumonia (n Z 24) 11 (13) 13 (8) 0.17
6 mo Z-score for weight (median (IQR)) 1.4 (2.0, 0.6) 1.1 (1.9, 0.4) 0.33
6 mo Z-score for length (median (IQR)) 1.2 (1.7, 0.8) 1.3 (1.9, 0.3) 0.98
a c2 test for trend.
Figure 3 Relationship between disease severity and health-
care seeking among infants with RSV infection. Infants with
LRTI were no more likely to seek a higher level of care for their
illness than those with an URTI (p value for trend Z 0.85).
RSV infection in infants in Nepal 151countries but not previously well described in a community-
based, rural setting.14
Our results suggest preterm infants should be a priority
group for RSV preventive interventions in resource-limited
settings. Importantly, as decisions are made about optimal
timing of maternal RSV vaccine administration, it will be
important to evaluate the role of preterm birth on RSV
antibody transfer and protection from severe lower respi-
ratory tract disease in specific populations. Preterm infants
have less transplacental transfer of maternal antibody and
more immature lungs compared to full-term infants, mak-
ing them more susceptible to severe lower respiratory tract
illness.15 A strategy to vaccinate women earlier in preg-
nancy may better protect the group with the highest inci-
dence of RSV ARI.
Longitudinal household-based weekly surveillance was
conducted over three full calendar years to accurately
estimate the incidence of symptomatic RSV ARI in infants
from birth to six months of age. The use of active surveil-
lance on a weekly basis minimizes recall bias, particularly
in households where multiple young children are present.16
In this study, 9% of infants had at least one RSV ARI episode,
with an incidence of 213/1000 person-years overall and
443/1000 person-years during RSV epidemic periods. This
compares to incidence rates of 70/1000 person-years in
children between 6 months and 10 years of age in Australia,
Singapore, and Colombia,17 345/1000 person-years in Ken-
yan infants,18 and 300/1000 person-years in rural Peru.19
RSV was highly seasonal with clear epidemics over three
years. Because of this marked seasonality, season of birth
Table 3 Factors associated with lower respiratory tract infection in infants with RSV.
Characteristics
Median (IQR) or n (%)
Upper respiratory
tract infection (n Z 84)
Lower respiratory
tract infection (n Z 203)
p-Value
Male gender 50 (60) 110 (54) 0.41
Low birthweight 25 (33) 47 (29) 0.45
Preterm birth 11 (13) 47 (23) 0.055
Small for gestational age 45 (60) 87 (53) 0.30
Other children under age five in household 44 (54) 104 (55) 0.90
Open indoor cookstove 72 (88) 176 (92) 0.32
Household latrine 34 (42) 70 (37) 0.45
Maternal primiparity 34 (41) 66 (32) 0.20
Maternal literacy 46 (60) 89 (50) 0.17
Visit for care 0.85a
No visit 23 (27) 58 (29)
Medicine shop or local doctor 15 (18) 47 (23)
Sub-health post or health post 37 (44) 66 (33)
Six-month Z-score for weight 1.1 (2.0, 0.5) 1.1 (1.9, 0.2) 0.58
Six-month Z-score for height 1.2 (1.9, 0.8) 1.3 (1.9, 0.4) 0.59
a c2 test for trend.
152 H.Y. Chu et al.was the primary risk factor for acquiring RSV. This degree of
seasonality is not seen in tropical regions for influenza, and
has not been found to be the case in other tropical regions,
such as Taiwan and Singapore, for RSV.20 This demonstrates
the need for year-round respiratory viral surveillance data
in the specific region of interest to guide public health
strategies.
Risk of RSV ARI was impacted by factors common in poor
rural communities, including lack of a household latrine,
use of open indoor cookstoves and multiple young children
in the household. For infants born during the RSV epidemic
period, maternal education was associated with protection.
Maternal education is likely a proxy for general socioeco-
nomic status and health care access, and not causally
associated with RSV ARI risk. There was no association
found between years of education and care-seeking among
mothers of kids with RSV. Though we did not find an
association of RSV infection with open biomass cookstove
use, only a minority of households used non-biomass
cookstoves limiting the power to detect an association.
Biomass stoves have been linked to increased risk for
pneumonia in children; however in a clinical trial in
Guatemala replacement of open cookstoves reduced risk
of severe pneumonia but did not reduce cases of RSV
pneumonia.21 We also did not find that other young children
in the same household increased RSV ARI risk; this may be
due to the high degree of intermixing of children between
households in dense, crowded village settings. In U.S.-
based epidemiologic studies, older siblings likely introduce
RSV to the infant.22,23 Likewise in Kenya, molecular epide-
miology studies have linked identical strains of RSV in older
children to the infants in the same household. In our
setting, vaccination of older children may not be a suffi-
cient strategy to protect young infants in the same
household.
A consideration in the performance of RSV vaccine trials
is the selection of clinical endpoints, including the use of
medically attended illness as an indicator of disease
severity.24,25 In resource-limited settings, health careaccess is impacted by several factors unrelated to illness
severity, including maternal education, poverty, distance
to a health care facility, cost related to transportation
and care, and gender.26 The use of medically attended
illness as a clinical endpoint would potentially exclude
participation of large sectors of the population and thereby
delay the introduction of an effective intervention. Though
we found a trend for seeking care at a hospital or from a
physician in infants with RSV LRTI, several infants with se-
vere pneumonia did not seek any care. A combination of
a clinical evaluation with health-care seeking behavior
would be more likely to accurately stratify disease severity.
We additionally compared the illness characteristics of
infants with RSV ARI between birth and two months to those
with a primary illness episode between two and six months
of age. Infants under two months of age are potentially
protected by higher levels of maternal antibody. However,
we did not find that younger infants had increased rates or
duration of symptoms compared to older infants. It is
possible that other factors, like malnutrition and hyper-
gammaglobulinemia, may lessen the transfer of RSV-
specific antibody and mitigate its early protective effect,
as in mothereinfant pairs in Papua New Guinea.27
Limitations of this study included the lack of collection
of swabs in asymptomatic infants, leading to an underes-
timation of the true incidence of RSV ARI. However, unlike
other respiratory viruses such as rhinovirus, a primary RSV
illness episode in a very young infant is rarely asymptom-
atic.28 Additional limitations of the study included the lack
of rhinorrhea as part of the definition of acute respiratory
illness. This likely reduced the detection of acute symptom-
atic RSV infection in young infants, in particular in those
without lower respiratory tract infections. Sampling was
performed only once a week, so it is also possible that
RSV was not detected in certain illness episodes with viral
shedding that lasted less than one week. One potential
explanation why premature infants had a higher incidence
of RSV infection is that they are more likely to have severe
infection, and therefore shed virus for prolonged periods of
RSV infection in infants in Nepal 153time, as has been shown with immunocompromised adults.
This would explain why detection would be more likely in
this population since sampling was performed only on a
weekly basis. An additional limitation was the lack of pulse
oximetry or chest radiographs to evaluate for pneumonia.
Severe or very severe pneumonia was defined according
to the WHO IMCI criteria; we believe the use of this defini-
tion is likely to be comparable across multiple studies in
resource-limited settings. Finally, the lack of first trimester
ultrasound was not available for accurate dating of gesta-
tional ages; this was not possible in rural Nepal and in parts
of the world where the majority of women receive limited
antenatal care and the majority of births occur at home.
Prevention of RSV in resource-limited settings has the
potential to significantly decrease severe illness in infants
under six months of age, particularly among those born
preterm. Further studies are needed to evaluate the
optimal strategy to prevent RSV in high-risk preterm infants
in resource-limited settings.
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